Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for China SXT Pharmaceuticals, Inc. (SXTC:NASDAQ), powered by AI.
China SXT Pharmaceuticals, Inc. is currently trading at $0.05. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for China SXT Pharmaceuticals, Inc. on Alpha Lenz.
View China SXT Pharmaceuticals, Inc.'s valuation metrics on Alpha Lenz.
“China SXT Pharmaceuticals, Inc.'s ROE is -27.5%. Explore profitability and growth together.”
Ask for details →China SXT Pharmaceuticals, Inc. is a specialty pharmaceutical company that focuses on the development, production, and sale of Chinese traditional medicine products. The company primarily engages in the creation of Advanced and Directly-Oral Solutions of Traditional Chinese Medicine Pieces (TCMPs) and Fine TCMPs, aiming to modernize and enhance the accessibility of traditional formulations. China SXT Pharmaceuticals caters to a diverse customer base, including hospitals, pharmacies, and end-consumers, by providing herbal and plant-based remedies that are deeply rooted in centuries-old Chinese medical practices. Positioned in the healthcare and pharmaceuticals sector, the company's innovations not only serve the domestic Chinese market but also seek to establish a global presence in the growing field of alternative medicine. Headquartered in Taizhou Jiangsu, China, China SXT Pharmaceuticals, Inc. plays a significant role in bridging traditional healing methods with contemporary healthcare demands, by leveraging unique, time-tested product offerings in a modern pharmaceutical context.
“China SXT Pharmaceuticals, Inc.'s ROE is -27.5%. Explore profitability and growth together.”
Ask for details →China SXT Pharmaceuticals, Inc. (ticker: SXTC) is a company listed on NASDAQ in the Healthcare sector (Drug Manufacturers - Specialty & Generic). It has approximately 75 employees.
The current price is $0.053 with a P/E ratio of -x and P/B of -x.
ROE is -27.49% and operating margin is -625.89%. Annual revenue is $1M.